Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Comparison Results
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$9.48B
20.83
-9.24%
―
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
226.49%
2 Buy
1 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$21.06B
-25.84
69.44%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.55B
-77.24
54.35%
2 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$24.51B
42.36
364.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
22.10
-1.74
-7.30%
HK:1672
Ascletis Pharma, Inc.
17.50
11.73
203.29%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.75
1.58
37.89%
HK:2162
Keymed Biosciences, Inc.
74.30
29.00
64.02%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.80
5.98
46.65%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
57.00
44.72
364.17%